COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00101127
Brief Title: Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

First Submitted : January 7, 2005
First Submitted that Met QC Criteria : January 7, 2005
First Posted : January 10, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : February 12, 2014
Last Update Posted : February 14, 2014 (Estimate)